Virtual Reality Component Reduces Risk of Falls in Elderly

Share this content:
Virtual Reality Component Reduces Risk of Falls in Elderly
Virtual Reality Component Reduces Risk of Falls in Elderly

FRIDAY, Aug. 12, 2016 (HealthDay News) -- For older adults at risk of falls, the addition of non-immersive virtual reality (VR) to treadmill training reduces the incidence of falls, according to a study published online Aug. 11 in The Lancet.

Anat Mirelman, Ph.D., from the Tel Aviv Sourasky Medical Center in Israel, and colleagues conducted a randomized trial at five clinical centers across five countries involving adults aged 60 to 90 years with high risk of falls. Participants with a history of two or more falls in the six months before the study were randomized to receive six weeks of treadmill training plus VR (154 adults) or treadmill training alone (148 adults).

The researchers found that the incident rate of falls was significantly lower in the treadmill training plus VR group in the six months after training (6.00 falls per six months; P < 0.0001 versus before training); the rate of falls did not decrease significantly in the treadmill training alone group (8.27 falls; P = 0.49). The incidence rate of falls was also significantly lower in the treadmill training plus VR group than in the treadmill training alone group at six months after the end of training (incident rate ratio, 0.58).

"In a diverse group of older adults at high risk for falls, treadmill training plus VR led to reduced fall rates compared with treadmill training alone," the authors write.

Two authors disclosed financial ties to the biopharmaceutical industry; several authors disclosed a patent application on the use of virtual reality.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »